EFFECTS OF FRUCTOSE LOADING IN STREPTOZOTOCIN-DIABETIC AND NONDIABETIC RATS

被引:16
|
作者
DAI, S [1 ]
MCNEILL, JH [1 ]
机构
[1] UNIV BRITISH COLUMBIA,FAC PHARMACEUT SCI,DIV PHARMACOL & TOXICOL,VANCOUVER V6T 1Z3,BC,CANADA
关键词
FRUCTOSE; DIABETES; HYPERTENSION; HYPERLIPIDEMIA; MYOCARDIAL DYSFUNCTION;
D O I
10.1139/y92-227
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study compares the cardiovascular consequences of a 6-week fructose feeding in nondiabetic and streptozotocin-diabetic rats. Myocardial performance of these animals was determined using the isolated perfused working heart preparation. Systolic blood pressure, pulse rate, ventricular weight/body weight ratio, and plasma levels of glucose, insulin, triglycerides, and cholesterol were measured. In nondiabetic rats, fructose drinking caused significant increases in blood pressure, pulse rate, and plasma concentrations of insulin and triglycerides. Streptozotocin-diabetic animals exhibited significantly less body weight growth, slower pulse rate, higher plasma levels of cholesterol and triglycerides, ventricular enlargement, and functional impairment of the myocardium. The fructose-loaded diabetic rats had larger increases in plasma cholesterol and triglycerides than did control fructose-fed rats, but the fructose-induced increases in blood pressure and pulse rate were attenuated significantly. However, plasma levels of glucose and insulin and the degree of ventricular enlargement and myocardial dysfunction were not significantly different from those of control diabetic rats. These results show that fructose loading for 6 weeks can cause increases in blood pressure, pulse rate, and plasma lipids in both nondiabetic and diabetic rats. However, fructose ingestion does not significantly alter glycemic control or affect the development of myocardial dysfunction in streptozotocin-diabetic rats.
引用
收藏
页码:1583 / 1589
页数:7
相关论文
共 50 条
  • [21] INTRATHYROIDAL THYROGLOBULIN IN STREPTOZOTOCIN-DIABETIC RATS
    LAMAS, L
    JOLIN, T
    ACTA ENDOCRINOLOGICA, 1986, 112 (04): : 552 - 558
  • [22] TUBULAR LESIONS IN STREPTOZOTOCIN-DIABETIC RATS
    RASCH, R
    DIABETOLOGIA, 1984, 27 (01) : 32 - 37
  • [23] NEUROPATHY AND MYOPATHY IN STREPTOZOTOCIN-DIABETIC RATS
    ROSSI, GL
    BESTETTI, G
    ZEMP, C
    PROBST, D
    DIABETOLOGIA, 1981, 21 (03) : 321 - 321
  • [24] TOXICITY STUDIES ON ONE-YEAR TREATMENT OF NONDIABETIC AND STREPTOZOTOCIN-DIABETIC RATS WITH VANADYL SULFATE
    DAI, S
    THOMPSON, KH
    VERA, E
    MCNEILL, JH
    PHARMACOLOGY & TOXICOLOGY, 1994, 75 (05): : 265 - 273
  • [25] EFFECTS OF AMINOGUANIDINE ON NERVE FUNCTION AND POLYOLS IN STREPTOZOTOCIN-DIABETIC RATS
    COTTER, MA
    CAMERON, NE
    DINES, K
    LOVE, A
    DIABETOLOGIA, 1992, 35 : A151 - A151
  • [26] SERUM-CHOLESTEROL LEVELS OF NONDIABETIC AND STREPTOZOTOCIN-DIABETIC RATS FED A HIGH CHOLESTEROL DIET
    HOLMGREN, PR
    BROWN, AC
    ARTERY, 1993, 20 (06) : 337 - 345
  • [27] Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats
    Oya, M
    Hosokawa, M
    Tsukada, H
    Fukuda, K
    Nakamura, H
    Tsukiyama, K
    Nagashima, K
    Fujimoto, S
    Yamada, Y
    Semo, Y
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 62 (02) : 69 - 77
  • [28] Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats
    Nangle, Matthew R.
    Gibson, T. Michael
    Cotter, Mary A.
    Cameron, Norman E.
    PLANTA MEDICA, 2006, 72 (06) : 494 - 500
  • [29] Effects and toxicity of Eugenia punicifolia extracts in streptozotocin-diabetic rats
    Brunetti, IL
    Vendramini, RC
    Januário, AH
    França, SC
    Pepato, MT
    PHARMACEUTICAL BIOLOGY, 2006, 44 (01) : 35 - 43
  • [30] Metabolic Effects of Sulforaphane Oral Treatment in Streptozotocin-Diabetic Rats
    de Souza, Carolina Guerini
    Sattler, Jose Augusto
    de Assis, Adriano Martimbianco
    Rech, Anderson
    Santos Perry, Marcos Luiz
    Souza, Diogo Onofre
    JOURNAL OF MEDICINAL FOOD, 2012, 15 (09) : 795 - 801